Answers are grounded in this paper and cite their sources.
Delivering high-quality craniospinal irradiation (CSI) remains challenging because of the need to achieve adequate target coverage across ultra-extended volumes while minimizing dose to normal tissue and maintaining clinically practical treatment efficiency. Although helical tomotherapy (HT) provides excellent dose conformity for CSI, prolonged delivery time and increased low-dose exposure may limit its clinical applicability. This study aimed to investigate whether increasing the number of isocenters in a gradient multi-isocenter volumetric modulated arc therapy (VMAT) strategy could enhance modulation capability for extended target volumes and provide a clinically feasible alternative to HT. Sixteen patients who received CSI at The Fourth Hospital of Hebei Medical University between January 2022 and March 2026 were retrospectively selected. For each patient, two VMAT strategies using an intelligent couch-shifting accelerator (TaiChiPro) were generated: a conventional multi-isocenter configuration (Group A) and an increased-isocenter configuration (Group B). HT plans delivered on a Radixact™ system were generated as reference plans (Group C). Dosimetric parameters of the planning target volume (PTV), organs at risk (OARs), low-dose exposure of normal tissue, monitor units (MU), delivery time, and patient-specific quality assurance results were evaluated. All plans met clinical dose constraints. Increasing the number of isocenters improved the dose modulation capability of VMAT for extended target volumes. Compared with the conventional VMAT approach, the increased-isocenter VMAT strategy achieved lower V 5 , V 10 , and D mean values for selected OARs, including the parotid glands and kidneys, as well as reduced low-dose exposure to normal tissue ( P < 0.05). Compared with HT, both VMAT strategies substantially reduced delivery time by approximately 78% (1355.98 ± 219.63 s vs. 301.08 ± 27.56 s vs. 302.30 ± 19.02 s, P < 0.001) and decreased low-dose exposure to selected normal tissue. HT maintained advantages in target conformity index (CI), homogeneity index (HI), as well as in reducing D max to selected central nervous system structures. However, no significant differences were observed between conventional and increased-isocenter VMAT regarding target coverage. Both VMAT strategies achieved clinically acceptable dose continuity across the target junction regions. Patient-specific quality assurance (QA) further demonstrated reliable delivery accuracy, with gamma passing rates exceeding 97% across all evaluated plans. A gradient multi-isocenter VMAT strategy implemented on an intelligent couch-shifting accelerator offers improved dose modulation for craniospinal irradiation while substantially improving delivery efficiency and reducing low-dose exposure to normal tissue. Increasing the number of isocenters may further improve OARs sparing without substantially increasing treatment time, while maintaining clinically acceptable target dose distributions. This approach provides a practical option for complex ultra-extended field radiotherapy, particularly in institutions without dedicated tomotherapy systems.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: